<?xml version="1.0" encoding="utf-8"?>

<rdf:RDF
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
  xmlns:admin="http://webns.net/mvcb/"
  xmlns:content="http://purl.org/rss/1.0/modules/content/"
  xmlns:cc="http://web.resource.org/cc/"
  xmlns="http://purl.org/rss/1.0/">

<channel rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/">
<title>The Health Care Blog</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/</link>
<description></description>
<dc:language>ar</dc:language>
<dc:creator></dc:creator>
<dc:date>2009-11-23T01:36:00-08:00</dc:date>
<admin:generatorAgent rdf:resource="http://www.typepad.com/?v=1.0" />


<items>
<rdf:Seq>" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
" />
</rdf:Seq>
</items>

</channel>

<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2009/11/conspiracy-theory-friday.html">
<title>Conspiracy theory Friday (FDA &amp; CCHIT related)</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2009/11/conspiracy-theory-friday.html</link>
<description>By Matthew Holt Two fun things—First, Mark Leavitt says he’s quitting CCHIT in March. He says that he’ll be 60 then and wants to go do other stuff. Of course the cynics among you will say that he’s had enough...</description>

<dc:subject>Electronic Medical Records</dc:subject>
<dc:subject>Health 2.0</dc:subject>
<dc:subject>HITECH</dc:subject>
<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2009-11-13T11:09:22-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2009/08/donald-light-sticks-it-to-phrma-and-tauzin-again.html">
<title>Donald Light sticks it to PhRMA and Tauzin, again</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2009/08/donald-light-sticks-it-to-phrma-and-tauzin-again.html</link>
<description>By Matthew Holt Over the years PhRMA must be getting pretty sick of Univ of Medicine and Denistry of New Jersey Professor Donald Light. He’s made a cottage industry of pissing on the commonly-trumpeted propaganda that only American drug research...</description>

<dc:subject>International</dc:subject>
<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2009-08-26T01:19:00-07:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2009/07/the-other-michael-jackson-mega-mix.html">
<title>The other Michael Jackson mega-mix</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2009/07/the-other-michael-jackson-mega-mix.html</link>
<description>By Matthew Holt Never ones to be shy with an interesting view into celebrity pharmacology (and truth be told responding to a little tickle from me) the inventive folks at PharmaSurveyor have added Michael Jackson to their celebrity drug cocktail...</description>

<dc:subject>Health 2.0</dc:subject>
<dc:subject>Pharma</dc:subject>
<dc:subject>pharmaceuticals</dc:subject>
<dc:subject>Technology</dc:subject>
<dc:subject>Web/Tech</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2009-07-06T02:00:00-07:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2009/03/my-forecast-a-sad-conclusion-to-the-health-care-bubble.html">
<title>My forecast: a sad conclusion to the health care bubble...</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2009/03/my-forecast-a-sad-conclusion-to-the-health-care-bubble.html</link>
<description>Brian Klepper and David Kibbe have written a terrific piece on how and why health care is in a handbasket and wondering where it’s going. But as we ex-futurists know, there’s lots of luck required to make a good forecast....</description>

<dc:subject>Health Plans</dc:subject>
<dc:subject>Matthew Holt</dc:subject>
<dc:subject>Pharma</dc:subject>
<dc:subject>Policy</dc:subject>
<dc:subject>Policy/Politics</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2009-03-12T02:41:00-07:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2009/01/should-the-fda.html">
<title>Should the FDA relax in the search for new cures?</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2009/01/should-the-fda.html</link>
<description>By Matthew Holt Over at DiabetesMine #1 health blogger Amy Tenderich has very important post. She and several fellow travelers are appealing to the FDA to strike a balance between safety and progress in allowing new diabetes treatments. The FDA...</description>

<dc:subject>e-patients</dc:subject>
<dc:subject>FDA</dc:subject>
<dc:subject>Health 2.0</dc:subject>
<dc:subject>Patient Safety</dc:subject>
<dc:subject>Pharma</dc:subject>
<dc:subject>pharmaceuticals</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2009-01-09T00:18:00-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2009/01/a-me-too-strate.html">
<title>A me-too strategy for me-too drugs</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2009/01/a-me-too-strate.html</link>
<description>By DAVID E. WILLIAMS AstraZeneca appears set to follow Merck into the market for “bio-similars.” (See AstraZeneca may join generic rush.) Congress and the media tend to portray biosimilars are analogous to generic chemistry-based pharmaceuticals, and therefore believe that they...</description>

<dc:subject>David E. Williams</dc:subject>
<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2009-01-04T19:00:00-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/12/weighing-in-on.html">
<title>Weighing in on the New FDA Commissioner </title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/12/weighing-in-on.html</link>
<description>By MERRILL GOOZNER Patient advocacy groups, most of them drug industry-funded, have asked President-elect Barack Obama to appoint a Food and Drug Administration commissioner who won&#39;t cave in to pressure from lawmakers or the news media, according to the Wall...</description>

<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-12-21T10:23:00-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/12/health-care-pro.html">
<title>Who should Obama pick for FDA Commissioner?</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/12/health-care-pro.html</link>
<description>By John Mack It seems like everyone in the Pharma Blogosphere and the press is recommending who president-elect Barack Obama should nominate as the new FDA Commissioner to replace Dr. Andrew von Eschenbach. A few weeks ago, I created the...</description>

<dc:subject>FDA</dc:subject>
<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-12-10T04:20:00-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/11/big-pharma-has.html">
<title>Big pharma has big problems</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/11/big-pharma-has.html</link>
<description>By David Williams Big pharma has big problems. The root cause is a lack of research and development productivity, which means a dearth of new products to make up for looming patent expirations. Something near half of big pharma’s revenues...</description>

<dc:subject>Economics</dc:subject>
<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-11-19T01:37:00-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/10/bad-light-falls.html">
<title>Researchers question publishing ethics of leading economics journal</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/10/bad-light-falls.html</link>
<description>By Sarah Arnquist Update: The Harvard Health Policy Review site is back up with an apology and disclaimer for not seeking a response from the JHE editors. A Harvard Health Policy Review article that details two researchers&#39; account of unethical...</description>

<dc:subject>Pharma</dc:subject>
<dc:subject>Policy</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-10-21T01:20:00-07:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/08/stanford-med-sc.html">
<title>Stanford Med School rejects industry funding for continuing education</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/08/stanford-med-sc.html</link>
<description>By Sarah Arnquist Stanford University&#39;s medical school announced this week new restrictions on educational contributions by drug and medical device companies, which turn out to be among the strictest in the nation. The rules are an effort to limit industry...</description>

<dc:subject>Medical Devices</dc:subject>
<dc:subject>Pharma</dc:subject>
<dc:subject>Sarah Arnquist</dc:subject>
<dc:subject>The Industry</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-08-28T00:46:00-07:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/08/identified-bull.html">
<title>Flacks peddle false &quot;reality&quot;</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/08/identified-bull.html</link>
<description>By Matthew Holt Such a pity that the NY Times has been so beaten up by the commies amongst us that it actually now feels that it has to point out where Peter Pitts and Janet Trautwein get their money....</description>

<dc:subject>Hillary Clinton</dc:subject>
<dc:subject>Matthew Holt</dc:subject>
<dc:subject>Pharma</dc:subject>
<dc:subject>Policy</dc:subject>
<dc:subject>Policy/Politics</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-08-15T08:11:00-07:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/08/viagra-prescrib.html">
<title>Viagra prescribed more safely online than in regular practice?</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/08/viagra-prescrib.html</link>
<description>By Matthew Holt Really? Can this be true? Well so says a bunch of academics writing in the Mayo Clinic’s journal. They looked at records of questionnaires taken and prescribing decisions made by a licensed, regulated online pharmacy called KwikMed...</description>

<dc:subject>Consumers</dc:subject>
<dc:subject>e-patients</dc:subject>
<dc:subject>Health 2.0</dc:subject>
<dc:subject>Pharma</dc:subject>
<dc:subject>pharmaceuticals</dc:subject>
<dc:subject>Technology</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-08-08T01:57:00-07:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/06/drug-advertisem.html">
<title>Drug advertisements annoying and possibly misleading</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/06/drug-advertisem.html</link>
<description>By Sean Neill Sean Neill is a South African-born, British-trained anesthesiologist, who recently relocated to Midwestern USA. He blogs regularly at OnMedica about his cross-cultural experience, frequently pointing out oddities of American health care. Watching television in America takes some...</description>

<dc:subject>Consumers</dc:subject>
<dc:subject>International</dc:subject>
<dc:subject>Pharma</dc:subject>
<dc:subject>The Industry</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-06-30T03:36:00-07:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/03/happy-birthday.html">
<title>Happy Birthday, Viagra!</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/03/happy-birthday.html</link>
<description>By Jane Sarasohn-Kahn It&#39;s the drug that raised the profile of medicine in popular culture. It&#39;s been hawked by a prominent politician and has been the butt of jokes on late-night TV. It&#39;s Viagara, and it&#39;s turning 10 today. The...</description>

<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-03-27T05:21:33-07:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/03/tech-drugs-tech.html">
<title>TECH: Drugs &amp; technology--Allscripts and SafeMed</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/03/tech-drugs-tech.html</link>
<description>To finish off the last but not least of my HIMSS interviews, here are two companies that both announced being part of the Google ecosystem on the Thursday of HIMSS. One is well known and a leader in ePrescribing and...</description>

<dc:subject>Pharma</dc:subject>
<dc:subject>Podcasts</dc:subject>
<dc:subject>Technology</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-03-02T23:46:00-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/02/physicians-grou.html">
<title>PHARMA: The ACP does the right thing</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/02/physicians-grou.html</link>
<description>In 1937 marijuana was banned by Congress. The only question asked was, &quot;what&#39;s the position of the American Medical Association?&quot;. It actually was in favor of keeping marijuana legal for medical purposes. But the response given to Congress by whoever...</description>

<dc:subject>Pharma</dc:subject>
<dc:subject>Physicians</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-02-19T00:15:00-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/02/pharma-the-stat.html">
<title>PHARMA: The statin backlash (or WSJ later than THCB by 5 years!)</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/02/pharma-the-stat.html</link>
<description>Yesterday the THCB hit meter went off the charts. not sadly because of some new genius posting on THCB, but because the WSJ has this article about Lipitor causing memory loss and Google searches are bring up an article from...</description>

<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-02-14T06:20:00-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/02/pharma-finally.html">
<title>PHARMA: Finally, a drug site that everyone can approve of!</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/02/pharma-finally.html</link>
<description>Yup, they really are cashing in on the Placebo Effect.</description>

<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-02-13T10:21:07-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/02/pharma-reprief.html">
<title>PHARMA: Reprieve for Amgen looking doubtful</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/02/pharma-reprief.html</link>
<description>In a story titled somewhat cryptically Medicare chief stands by anemia move (do they mean he’s trying to become anemic?) Reuters reports that CMS is not backing down from its decision to radically cut payments for anti-anemia drugs for chemotherapy...</description>

<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-02-08T14:35:54-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/02/pharma-stunt-do.html">
<title>PHARMA: Stunt doubles in pharma DTC?</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/02/pharma-stunt-do.html</link>
<description>I’m sure (well I’m not sure but I’ll cheerfully and casually postulate) to keep you all amused on a Friday) that there are many possible overlooked problems with Lipitor and the statins. I’ve heard of severe muscle pain, even amnesia....</description>

<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-02-08T12:32:00-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/02/policypharma-de.html">
<title>POLICY/PHARMA: DEA&#39;s insane persecution of pain patients continues</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/02/policypharma-de.html</link>
<description>Just in case you needed to be reminded that the DEA is a refuge of evil scumbags and needs to be abolished, here&#39;s another exhibit (from the good people at DRCNet): Federal agents arrested Dr. Stephen Schneider, operator of the...</description>

<dc:subject>Pharma</dc:subject>
<dc:subject>Policy</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-02-01T07:52:49-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/01/pharmatech-drug.html">
<title>PHARMA/TECH: Drug interaction checkers and more</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/01/pharmatech-drug.html</link>
<description>I&#39;m up over at the Health 2.0 Blog talking about my favorite drug interaction checker. Meanwhile if you (yes, that means you) want to write on the Health 2.0 Blog, please email me and let me know.</description>

<dc:subject>Health 2.0</dc:subject>
<dc:subject>Pharma</dc:subject>
<dc:subject>Technology</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-01-17T15:55:11-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2008/01/pharma-talking.html">
<title>PHARMA: Talking of gotcha&#39;s...</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2008/01/pharma-talking.html</link>
<description>Schering Plough is coming under multo criticism the last two days for sitting on data for up to a year that shows that the anti-cholesterol drug Zetia, when combined with Merk’s Zocor in the combo drug Vytorin, not only didn’t...</description>

<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2008-01-16T09:18:16-08:00</dc:date>
</item>
<item rdf:about="http://www.thehealthcareblog.com/the_health_care_blog/2007/12/blogs-diabetes.html">
<title>BLOGS: Diabetes Year in Review</title>
<link>http://www.thehealthcareblog.com/the_health_care_blog/2007/12/blogs-diabetes.html</link>
<description>Our friend and colleague Amy Tenderich has a just excellent Diabetes Year in Review up at DiabetesMine. It covers Health 2.0 (of course) but also drugs devices, design, and the growth of people with diabetes as a social force. Amy...</description>

<dc:subject>Consumers</dc:subject>
<dc:subject>Health 2.0</dc:subject>
<dc:subject>Pharma</dc:subject>

<dc:creator>Matthew</dc:creator>
<dc:date>2007-12-18T01:05:00-08:00</dc:date>
</item>


</rdf:RDF><!-- ph=1 -->
<!-- nhm:from_kauri -->
